Our long-term objective is to understand how bile acids modify cholangiocyte biology. We continue to focus on bile acid interactions with cholangiocytes, the epithelial cells lining intrahepatic bile ducts, because of the development of new hypotheses and techniques regarding the regulation of bile acid transport by posttranslational modification of the apical bile acid transporter (ASBT). We have found ASBT protein expression in the cholangiocyte apical membrane is rapidly regulated by a reversible process (due to apical membrane recycling) and by a nonreversible process (due to ubiquitination). This rapid regulation of ASBT is important to changes in bile secretion and to the adaptive response to .cholestasis and inflammation. In the first specific aim, the hypothesis that ASBT recycles between intracellular and apical membranes will be tested by novel technology using apical membrane biotinylation and fluorescence microscopy and polarized cells expressing ASBT-GFP. In the second specific aim, the hypothesis that ASBT phosphorylation and monoubiquitination regulates ASBT endocytosis/exocytosis will be tested by examining phosphorylation, monoubiquitination and ASBT translocation in polarized cells expressing wild, phosphorylation deficient and constitutively phosphorylated mutants or mutants that lack lysine ubiquitination sites. In the third specific aim, the hypothesis that phosphorylation triggers ASBT ubiquitination and proteasome degradation will be tested by determining ASBT polyubiquitination in normal cells or ubiquitination-deficient cells, by strategic lysine replacements mutations to test if there is a """"""""lysine destruction motif adjacent to a regulatory phosphorylation site, and studies to determine the intracellular site, where ASBT is ubiquitinated: The results of these studies will clarify the mechanisms for posttranslational regulation of ASBT and will offer new insights into cholangiocyte function and for the understanding of cholestatic liver diseases, where the cholangiocyte is the principle target.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054208-11
Application #
7760955
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Serrano, Jose
Project Start
2000-09-30
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2012-01-31
Support Year
11
Fiscal Year
2010
Total Cost
$284,414
Indirect Cost
Name
East Tennessee State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051125037
City
Johnson City
State
TN
Country
United States
Zip Code
37614
Yin, Deling; Yang, Xiaohua; Li, Hui et al. (2016) ?-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein. J Biol Chem 291:605-12
Jung, Dongju; York, J Philippe; Wang, Li et al. (2014) FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. Pflugers Arch 466:1011-9
Xia, Xuefeng; Jung, Dongju; Webb, Paul et al. (2012) Liver X receptor ýý and peroxisome proliferator-activated receptor ýý regulate cholesterol transport in murine cholangiocytes. Hepatology 56:2288-96
Xia, Xuefeng; Demorrow, Sharon; Francis, Heather et al. (2007) Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis 27:401-12
Xia, Xuefeng; Francis, Heather; Glaser, Shannon et al. (2006) Bile acid interactions with cholangiocytes. World J Gastroenterol 12:3553-63
Shifrin, Alexander L; Chirmule, Narendra; Gao, Guang-Ping et al. (2005) Innate immune responses to adenoviral vector-mediated acute pancreatitis. Pancreas 30:122-9
Marzioni, Marco; Glaser, Shannon; Francis, Heather et al. (2005) Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 128:121-37
Alpini, Gianfranco; Glaser, Shannon; Baiocchi, Leonardo et al. (2005) Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology 41:1037-45
Alpini, Gianfranco; Kanno, Noriatsu; Phinizy, Jo Lynne et al. (2004) Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 286:G973-82
Francis, Heather; Glaser, Shannon; Ueno, Yoshiyuki et al. (2004) cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 41:528-37

Showing the most recent 10 out of 29 publications